Dozens of startups have jumped into the weight-loss market this year as weight-loss drugs, including Wegovy and Ozempic, have exploded in popularity.
The few companies with enough money and brand recognition to stand up to Ozempic's distribution challenges — WeightWatchers, Noom, and Ro — can expect to compete for market dominance next year.
But WeightWatchers signaled it's going all in on weight-loss drugs by launching its own behavioral program for patients on Ozempic in December.
WeightWatchersLike WeightWatchers, Noom has remained staunchly in the weight-loss market since its 2008 launch.
Ro launched its own program prescribing weight-loss drugs in January.
Persons:
VCs, — WeightWatchers, Sari Kaganoff, WeightWatchers, it's, Sima Sistani, Noom, Ro, Zach Reitano, Kaganoff, Saeju Jeong, Sam Barnes, Aaron DeGagne
Organizations:
Business, Rock Health, Web, Getty, PitchBook
Locations:
Ozempic